The PEPPER trial will enroll approximately 20,000 patients across over 25 sites in North America. Enrollment is now closed, however, to learn more about the trial, you may contact the PEPPER Program Director, Carol Lambourne at 603-653-6195 or carol.a.lambourne@hitchcock.org. You may also contact a site principal investigator at a participating institution near you from the list below.